Literature DB >> 16890661

Contribution of 11C-choline positron emission tomography/computerized tomography to preoperative staging of advanced transitional cell carcinoma.

Ofer N Gofrit1, Eyal Mishani, Marina Orevi, Martine Klein, Nanette Freedman, Dov Pode, Amos Shapiro, Ran Katz, Eugene Libson, Roland Chisin.   

Abstract

PURPOSE: Current imaging modalities for preoperative staging of advanced transitional cell carcinoma of the bladder or upper urinary tract are not sensitive for detection of metastases. This study examines the contribution of 11C-choline positron emission tomography/computerized tomography to preoperative staging of transitional cell carcinoma.
MATERIALS AND METHODS: We prospectively evaluated 18 patients with 19 advanced transitional cell carcinomas (17 bladder tumors and 2 upper tract transitional cell carcinomas). All patients had computerized tomography of the chest, abdomen and pelvis negative for metastases. 11C-choline positron emission tomography/computerized tomography was performed on a Discovery ST(R) positron emission tomography/computerized tomography system. Finally 16 patients underwent radical surgery and positron emission tomography/computerized tomography images were compared to histopathological findings. Two patients were not operated on due to the findings on 11C-choline positron emission tomography/computerized tomography.
RESULTS: 11C-choline uptake was found in all primary transitional cell carcinomas, with a maximum standardized uptake value of 7.3 +/- 3.2 (mean +/- SD). The series included 3 patients with refractory bladder carcinoma in situ, which was visualized in all 3, with a standardized uptake value of 6.9 +/- 5.6. In 6 patients uptake of 11C-choline in lymph nodes as small as 5 mm was visualized (standardized uptake value 3.8 +/- 1.4). Of these patients 4 underwent surgery and histopathology confirmed malignancy in 3 of 4. No additional patients with positive lymph nodes were found on histopathology. Metastases were visualized in bones with normal architecture on computerized tomography in 4 patients (standardized uptake value 5.2 +/- 1.1) and were confirmed by followup computerized tomography.
CONCLUSIONS: In this small series 11C-choline positron emission tomography/computerized tomography was highly sensitive for primary and metastatic transitional cell carcinoma. Carcinoma in situ, lymph node metastases and early bony metastases were visualized. 11C-choline positron emission tomography/computerized tomography is a promising tool for preoperative staging of advanced transitional cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16890661     DOI: 10.1016/j.juro.2006.04.018

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  17 in total

Review 1.  [Impact of nuclear medicine imaging techniques for lymph node surgery].

Authors:  L S Freudenberg; G Holl; S P Müller; S J Rosenbaum-Krumme; J Sciuk; A Bockisch
Journal:  Urologe A       Date:  2009-01       Impact factor: 0.639

2.  Comparative sensitivity and specificity of imaging modalities in staging bladder cancer prior to radical cystectomy: a systematic review and meta-analysis.

Authors:  Jack Crozier; Nathan Papa; Marlon Perera; Brian Ngo; Damien Bolton; Shomik Sengupta; Nathan Lawrentschuk
Journal:  World J Urol       Date:  2018-08-17       Impact factor: 4.226

Review 3.  Diagnostic accuracy of C-11 choline and C-11 acetate for lymph node staging in patients with bladder cancer: a systematic review and meta-analysis.

Authors:  Seong-Jang Kim; Phillip J Koo; Kyoungjune Pak; In-Ju Kim; Keunyoung Kim
Journal:  World J Urol       Date:  2018-01-02       Impact factor: 4.226

Review 4.  PET/Computed Tomography in Renal, Bladder, and Testicular Cancer.

Authors:  Kirsten Bouchelouche; Peter L Choyke
Journal:  PET Clin       Date:  2015-04-24

5.  [Functional imaging in bladder cancer].

Authors:  T Maurer; T Horn; A J Beer; M Eiber; J E Gschwend
Journal:  Urologe A       Date:  2013-04       Impact factor: 0.639

6.  PET/CT and MRI in Bladder Cancer.

Authors:  Kirsten Bouchelouche; Baris Turkbey; Peter L Choyke
Journal:  J Cancer Sci Ther       Date:  2012-07-30

Review 7.  Interrogating tumor metabolism and tumor microenvironments using molecular positron emission tomography imaging. Theranostic approaches to improve therapeutics.

Authors:  Orit Jacobson; Xiaoyuan Chen
Journal:  Pharmacol Rev       Date:  2013-09-24       Impact factor: 25.468

Review 8.  Positron emission tomography (PET) in the urooncological evaluation of the small pelvis.

Authors:  S Machtens; J Serth; A Meyer; C Kleinhorst; K-J Ommer; U Herbst; M Kieruij; A R Boerner
Journal:  World J Urol       Date:  2007-07-12       Impact factor: 4.226

Review 9.  [Molecular multimodal hybrid imaging in prostate and bladder cancer].

Authors:  T Maurer; M Eiber; B J Krause
Journal:  Urologe A       Date:  2014-04       Impact factor: 0.639

10.  Retroperitoneal lymph nodes in transitional cell carcinoma of the kidney and ureter.

Authors:  Shilajit D Kundu; Scott E Eggener
Journal:  Adv Urol       Date:  2009-01-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.